Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal interstitial lung disease that is often associated with elevation in pulmonary artery pressures. Although pulmonary arterial hypertension has been associated with primary graft dysfunction (PGD), the role of secondary pulmonary hypertension in PGD risk is incompletely understood. The purpose of this study was to evaluate whether increased mean pulmonary artery pressure (mPAP) is a clinical risk factor for the development of severe PGD in patients with IPF.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
